Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Seidman

Showing results (511-520 of 533) with videos related to

Pageof 54
Sort By:
JAMA Cardiology|September 6, 2023
Cardiac Remodeling in Subclinical Hypertrophic Cardiomyopathy: The VANISH Randomized Clinical TrialChristoffer Rasmus Vissing, Anna Axelsson Raja, Sharlene M Day, et al.
Nature Medicine|September 24, 2021
Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trialCarolyn Y Ho, Sharlene M Day, Anna Axelsson, et al.
Nature Genetics|July 1, 2020
Genomic analyses implicate noncoding de novo variants in congenital heart diseaseFelix Richter, Sarah U Morton, Seong Won Kim, et al.
Nature Genetics|November 22, 2016
Titin-truncating variants affect heart function in disease cohorts and the general populationSebastian Schafer, Antonio de Marvao, Eleonora Adami, et al.
Science (New York, N.Y.)|January 20, 2016
De novo mutations in congenital heart disease with neurodevelopmental and other congenital anomaliesJason Homsy, Samir Zaidi, Yufeng Shen, et al.
American Heart Journal|June 2, 2020
Expanding the clinical and genetic spectrum of ALPK3 variants: Phenotypes identified in pediatric cardiomyopathy patients and adults with heterozygous variantsJohanna C Herkert, Judith M A Verhagen, Raquel Yotti, et al.
Journal of the American College of Cardiology|May 20, 2026
Sex and Age Specific Genetic Risk Across the Dilated and Arrhythmogenic Cardiomyopathy Spectrum: Insights From the SHaRe RegistrySophie L V M Stroeks, Nicole K Bart, Joseph Rossano, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 24, 2025
Genomic analysis of 11,555 probands identifies 60 dominant congenital heart disease genesMichael C Sierant, Sheng Chih Jin, Kaya Bilguvar, et al.
Science Translational Medicine|January 16, 2015
Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and diseaseAngharad M Roberts, James S Ware, Daniel S Herman, et al.
Nature Genetics|October 10, 2017
Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probandsSheng Chih Jin, Jason Homsy, Samir Zaidi, et al.
Pageof 54

Showing results (511-520 of 533) with videos related to

Sort By:
Pageof 54
JAMA Cardiology|September 6, 2023
Cardiac Remodeling in Subclinical Hypertrophic Cardiomyopathy: The VANISH Randomized Clinical TrialChristoffer Rasmus Vissing, Anna Axelsson Raja, Sharlene M Day, et al.
Nature Medicine|September 24, 2021
Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trialCarolyn Y Ho, Sharlene M Day, Anna Axelsson, et al.
Nature Genetics|July 1, 2020
Genomic analyses implicate noncoding de novo variants in congenital heart diseaseFelix Richter, Sarah U Morton, Seong Won Kim, et al.
Nature Genetics|November 22, 2016
Titin-truncating variants affect heart function in disease cohorts and the general populationSebastian Schafer, Antonio de Marvao, Eleonora Adami, et al.
Science (New York, N.Y.)|January 20, 2016
De novo mutations in congenital heart disease with neurodevelopmental and other congenital anomaliesJason Homsy, Samir Zaidi, Yufeng Shen, et al.
American Heart Journal|June 2, 2020
Expanding the clinical and genetic spectrum of ALPK3 variants: Phenotypes identified in pediatric cardiomyopathy patients and adults with heterozygous variantsJohanna C Herkert, Judith M A Verhagen, Raquel Yotti, et al.
Journal of the American College of Cardiology|May 20, 2026
Sex and Age Specific Genetic Risk Across the Dilated and Arrhythmogenic Cardiomyopathy Spectrum: Insights From the SHaRe RegistrySophie L V M Stroeks, Nicole K Bart, Joseph Rossano, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 24, 2025
Genomic analysis of 11,555 probands identifies 60 dominant congenital heart disease genesMichael C Sierant, Sheng Chih Jin, Kaya Bilguvar, et al.
Science Translational Medicine|January 16, 2015
Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and diseaseAngharad M Roberts, James S Ware, Daniel S Herman, et al.
Nature Genetics|October 10, 2017
Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probandsSheng Chih Jin, Jason Homsy, Samir Zaidi, et al.
Pageof 54